Filing Details
- Accession Number:
- 0001645627-17-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-24 13:27:14
- Reporting Period:
- 2016-12-12
- Filing Date:
- 2017-02-24
- Accepted Time:
- 2017-02-24 13:27:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-12-12 | 1,000 | $0.07 | 19,593,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-13 | 1,000 | $0.07 | 19,594,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-13 | 950 | $0.07 | 19,595,365 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-13 | 50 | $0.07 | 19,595,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-16 | 1,000 | $0.07 | 19,596,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-16 | 1,000 | $0.07 | 19,597,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-16 | 1,000 | $0.07 | 19,598,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-16 | 50 | $0.07 | 19,598,465 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-16 | 950 | $0.07 | 19,599,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-16 | 1,000 | $0.07 | 19,600,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-19 | 1,000 | $0.07 | 19,601,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-19 | 50 | $0.06 | 19,601,465 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-19 | 950 | $0.07 | 19,602,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-19 | 1,000 | $0.07 | 19,603,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-19 | 1,000 | $0.07 | 19,604,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-19 | 50 | $0.07 | 19,604,465 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-19 | 950 | $0.07 | 19,605,415 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-19 | 200 | $0.07 | 19,605,615 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-22 | 1,000 | $0.06 | 19,606,615 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-22 | 1,000 | $0.06 | 19,607,615 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-22 | 1,000 | $0.06 | 19,608,615 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-23 | 1,000 | $0.06 | 19,609,615 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-23 | 1,000 | $0.06 | 19,610,615 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-23 | 1,000 | $0.06 | 19,611,615 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-27 | 1,000 | $0.06 | 19,612,615 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-27 | 1,000 | $0.06 | 19,613,615 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-28 | 1,000 | $0.06 | 19,614,615 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-28 | 1,000 | $0.06 | 19,615,615 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-28 | 200 | $599.00 | 19,615,815 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-12-28 | 300 | $0.06 | 19,616,115 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |